Vanguard Portfolio Management
JANX icon

Vanguard Portfolio Management’s Janux Therapeutics JANX Stock Holding History

Vanguard Portfolio Management’s Portfolio JANX Stock Details JANX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$20.4M Buy
1,330,710
+40,454
+3% +$586K ﹤0.01% 1991
2026
Q1 		$17.9M Buy
+1,290,256
New +$17.7M ﹤0.01% 1939

Other funds holding JANX

RCM
RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $69.6B AUM 42.52% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $90.7B AUM 77.13% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
TCM
TCG Crossover Management Palo Alto, California $4.16B AUM 983.43% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.91% 1-Year Est. Return

Vanguard Portfolio Management's JANX Position: Q2 2026 in Review

Vanguard Portfolio Management increased its Janux Therapeutics (JANX) stake by 3.1% in Q2 2026, buying an estimated $586K and bringing the position to 1,330,710 shares worth $20.4M. The position accounts for ﹤0.01% of the portfolio, ranked #1991.

Vanguard Portfolio Management first reported a position in JANX in Q1 2026 and has held it in 2 quarters since. 180 funds tracked by Wall St. Rank hold JANX as of Q2 2026.

  • Vanguard Portfolio Management held 1,330,710 shares of Janux Therapeutics worth $20.4M as of Q2 2026.
  • Vanguard Portfolio Management bought 40,454 Janux Therapeutics shares in Q2 2026, an estimated $586K.
  • Janux Therapeutics made up ﹤0.01% of Vanguard Portfolio Management's portfolio in Q2 2026, its #1991 holding.
  • Vanguard Portfolio Management first reported a position in Janux Therapeutics in Q1 2026 and has held it in 2 quarters since.
  • 180 funds tracked by Wall St. Rank held Janux Therapeutics as of Q2 2026.

Based on Vanguard Portfolio Management's 13F filing for Q2 2026, filed 13 Aug 2026.